Teva drug meets endpoints in celiac disease trial
Globes
The antibody TEV ‘408 (anti-IL 15) was also tested as a treatment for the skin disease vitiligo, and there it also presented encouraging findings.
GlobesGlobesThe antibody TEV ‘408 (anti-IL 15) was also tested as a treatment for the skin disease vitiligo, and there it also presented encouraging findings.